Nonmotor Symptoms Groups in Parkinson's Disease Patients: Results of a Pilot, Exploratory Study

Table 1

Patients characteristics.

Males/Females (%)	36 (51)/35 (49)
Age (Mean ± SD)	68.5 ± 8.7
UPDRS II+III in ON (Mean ± SD)	29.1 ± 14.1
Hoehn&Yahr score
I	10 (14)
I.5	13 (18)
II/II.5	23 (32)
III	16 (23)
IV/V	9 (13)
PD duration (Mean ± SD)	7.7 ± 5.7 years; (range: 1–20)
No dopaminergic therapy (%)	15 (21)
Levodopa (%)	45 (63)
Dopamine agonists (%)	42 (60)
LDED (Mean ± SD)	596 ± 462
Diskinesias (%)	34 (47)
Wearing off (%)	35 (49)

LDED: levodopa equivalent daily dose; PD: Parkinson’s Disease; SD: standard deviation.